EUFOREA is pleased to present its upcoming and first consensus meeting of the year on Biologics for Type 2 respiratory disease at the Harvard Club, Boston, on Friday, 6th February, to discuss “which biologic for what respiratory condition: indications, considerations and clinical follow-up”.
EUFOREA brings internationally renowned US experts as co-chairs: Professor Stella Lee (USA), Professor Benjamin Bleier (USA), Professor Kathleen Buchheit, and Professor Tanya Laidlaw (USA). In addition to our expert panel, the meeting will be attended by the EUFOREA Chairman, Professor Peter Hellings (Belgium), members of the EUFOREA Management team, and industry partners, who will be allowed to input into our discussions.
Click here for the programme of this closed consensus meeting!
